Character | Results |
---|---|
Females (%) | 353 (74) |
Median age in years at diagnosis (25-75th percentile) | 6.32 (3.05–10.00) |
Median years in disease duration (25-75th percentile) | 4.04 (2.00–8.00) |
Median baseline AJC (25-75th percentile) | 16.00 (9.00–27.00) |
Median baseline ESR (25-75th percentile) | 28 (13–47) |
Baseline RF positive (%) | 124 (26) |
Baseline MTX treatment (%) | 322 (67) |
Baseline prednisone treatment (%) | 214 (45) |